By week 4 to 6, the majority of tirzepatide patients report that side effects have resolved while therapeutic benefitssteady weight loss, improved satiety, and better blood sugar controlbecome evident
Preventing Weight Regain - This One is Important
An ever-growing market Morgan Stanley estimated in May that the global market for obesity drugs could reach up to $150 billion (128bn) by 2035, up from a previous prediction of $105 billion (89.7bn)
The volume of diluent (D5W or 0.45% sodium chloride) needed to be adjusted based on weight to avoid fluid overload, and hyponatremia: 520 kg: 3 mL/kg 5% dextrose in water infused over 60 min
If considering a dose reduction for maintenance: Wait until weight has stabilized for at least 4 weeks at your current dose Reduce by one dose step (e.g., 12mg to 8mg), do not jump multiple steps Monitor weight closely for 8 weeks after the reduction If weight begins to increase, return to the previous maintenance dose The phase 3 trials specifically tested 4mg as a maintenance dose, suggesting Lilly sees viability in lower maintenance doses What happens if you stop Weight regain after discontinuing GLP-1 agonists is well documented with semaglutide and tirzepatide
.png)
&srotate=0)
